[ad_1] WILMINGTON, Mass., October 12, 2021–(BUSINESS WIRE)–Charles River Laboratories International, Inc. (NYSE: CRL) announced that it has divested its Research Models and Services operations in Japan (RMS Japan) and its gene therapy CDMO site in Sweden (CDMO Sweden) in two separate transactions. RMS Japan Divestiture On October 12th, the Company completed the sale of its